Murata et al. (2013) examined the clinical and prognostic features of p53 immunohistochemical expression in 266 ESCC patients and found that the protein expression has no impact on the prognosis of ESCC, according to them, possibly due to their short follow-up time [47]. Here, TP53 is linked to esophageal squamous cell carcinoma.